HOME CONTACT ABOUT PRODUCT PIPELINE RESOURCES PARTNERING INVESTORS MEDIA CAREERS Management Team Stephen R. Davis Chief Executive Officer Serge Stankovic, M.D., M.S.P.H. President Austin D. Kim Executive Vice President, General Counsel and Secretary Brendan Teehan Executive Vice President, Chief Operating Officer, Head of Commercial Kathie M. Bishop, Ph.D. Senior Vice President, Head of Rare Disease and External Innovation Daryl DeKarske Senior Vice President, Global Head of Regulatory Affairs and Head of Translational Sciences Stephanie Fagan Senior Vice President, Corporate Affairs and Chief Communications Officer Julie Fisher Senior Vice President, Marketing and Commercial Strategy Bob Mischler Senior Vice President, Strategy and Technology Operations Mark Schneyer Senior Vice President, Business Development, Chief Business Officer and Interim Chief Financial Officer Ponni Subbiah, M.D., M.P.H. Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer Mary Ellen Turner, M.D., M.P.H. Senior Vice President, Pharmacovigilance and Corporate Safety Officer ABOUT MANAGEMENT TEAM BOARD OF DIRECTORS OUR PURPOSE, MISSION & VALUES HISTORY Print page Share PRIVACY COOKIES PRIVACY SHIELD TERMS EMAIL © 2021 Acadia Pharmaceuticals Inc. Acadia and NUPLAZID are registered trademarks of Acadia Pharmaceuticals Inc. All rights reserved. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. For further details on cookies, how we use cookies and how to delete or block the use of cookies, please read our .